Model Standing Order and Immunization Protocol Template
A. Check the ALERT Immunization Information System (IIS) to determine whether the patient needs this vaccine. If ALERT IIS is unavailable, use available documentation and patient statement. B. Screen client for contraindications and precautions. C. Provide a Vaccine Information Fact Sheet for Recipients and Caregivers , and answer any questions.
Download Model Standing Order and Immunization Protocol Template
Information
Domain:
Source:
Link to this page:
Documents from same domain
FREQUENTLY ASKED QUESTIONS ABOUT SICK LEAVE
www.oregon.govFREQUENTLY ASKED QUESTIONS ABOUT SICK LEAVE AGENCIES SHOULD NOT RELY ONLY ON THIS GUIDE.Always refer to relevant agency policies, State HR policies,
ORARNG Pam 350-5 1 October 2013 OREGON …
www.oregon.govorarng pam 350-5 1 october 2013 2 standard operating procedures (sop) oregon training center part one, general information index 1. general: 8
333-061-0036 Sampling and Analytical Requirements
www.oregon.govOAR 333-061-0036(1) Page 3 of 102 Effective January 10, 2018 the water system, public water system identification number, sampling date, and
regon Department of Transportation - oregon.gov
www.oregon.govAttachment 75A FORM 734-2352 (6-16) STK#202212
OREGON TRAFFIC ACCIDENT AND INSURANCE …
www.oregon.govOREGON TRAFFIC ACCIDENT AND INSURANCE REPORT. STK# 300009. Oregon law requires these reports be filed within 72 hours of the accident. If you are not able to file within the 72 hours,
1 CHAPTER 407 2 3
www.oregon.gov0 1 chapter 407 2 department of human services, 3 administrative services division and director’s office 4 5 division 7 6 criminal records and abuse check rules 7 8 rules 0000 - …
(Instructions on back) - oregon.gov
www.oregon.govcertification of oregon residency or domicile 735-7182 (11-11) section 1 – customer information name residence address mailing address (if different) city zip code
Gun Data Codes 2017 As of September 30, - …
www.oregon.gov1 - Gun Data Codes Introduction September 30, 2017 2 Section 2 contains MAK Field codes listed alphabetically by gun manufacturer. If a make is …
FREQUENTLY ASKED QUESTIONS ABOUT …
www.oregon.govPossibly. The legalization of recreational marijuana does not affect employers’ obligations with regard to medical marijuana (which …
Material Risk Notice - oregon.gov
www.oregon.govMaterial Risk Notice Form created by the Oregon Medical Board for use by healthcare professionals to be retained as part of the patient’s permanen t medical record. ...
Related documents
VACCINE INFORMATION STATEMENT Influenza Vaccine
stacks.cdc.govThe person giving you the vaccine can give you more information. 4. Risks of a vaccine reaction. With a vaccine, like any medicine, there is a chance of side effects. These are usually mild and go away on their . own. Problems that could happen after any vaccine: • Severe allergic reactions from a vaccine are very rare,
COVID-19 Janssen Vaccine Biological Page
www.albertahealthservices.caCOVID-19 vaccine be offered an additional dose of mRNA vaccine as a booster dose at least 5 calendar months after the single dose. • With a vaccine effectiveness between 67 and 72%, an additional dose of mRNA vaccine is recommended to provide better protection. This does not apply to individuals who received any dose of mRNA vaccine previously.
Vaccine Information Statement: Recombinant Zoster ...
www.cdc.govRecombinant Zoster Vaccine 2/04/2022 ONLY Vaccine Information Statement 3. Talk with your health care provider Tell your vaccination provider if the person getting the vaccine: Has had an allergic reaction after a previous dose of recombinant shingles vaccine, or has any severe, life-threatening allergies
COVID-19 Vaccine AstraZeneca - Embolic and thrombotic ...
www.ema.europa.euVaccine (ChAdOx1-S [recombinant]) – COVID-19 Vaccine AstraZeneca (Other viral vaccines) EMA/PRAC/157045/2021 Page 5/50 artery thrombosis, cerebral venous sinus thrombosis. Other reported events included pulmonary embolism (8), thrombocytopenia (6), disseminated intravascular coagulation (4), deep vein thrombosis
Vaccine Information Statement: Inactivated Influenza Vaccine
www.immunize.orgVaccine Information Statement • Influenza, Inactivated (8/6/21)• Arabic Translation • Distributed by the Immunization Action Coalition Influenza (inactivated or recombinant) VIS – Arabic (8/6/21) عم ازنولفنلإا ميعطت نوذخأي نيذلا راغصلا لافطلأا حبصي دقو ...
Vaccine Information Statement: Inactivated Influenza …
www.immunize.orgVaccine Information Statement 4. Risks of a vaccine reaction Soreness, redness, and swelling where the shot is given, fever, muscle aches, and headache can happen after influenza vaccination. There may be a very small increased risk of Guillain-Barré Syndrome (GBS) after inactivated influenza vaccine (the flu shot).